P764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA. (23rd June 2022) - Gonzalez, J.; Perusini, A.; Russo, F.; Fuentes, L.; Deluca, T.; Basquiera, A. L.; Navickas, A.; Kornblihtt, L.; Pintos, N.; Nucifora, E.; Iastrebner, M.; Enrico, A.; et al.